Skip to Main Content

Christy Zheng

DownloadHi-Res Photo

About

Biography

Christy received her Bachelors in Biology and Asian Languages & Cultures in 2022 from the University of Wisconsin-Madison, where she worked as an undergraduate research assistant in the lab of Dr. Elaine Alarid studying the function of the transcription factor Grainyhead-like protein 2 in estrogen receptor (ER) positive breast cancer. Following graduation, she remained in the lab as a research technician/specialist and lab manager over the next two years, further delving into the metastatic potential and plasticity of ER positive breast cancer. In March 2025, Christy joined the Muzumdar lab as a PhD student interested in the interplay of GLP-1 receptor agonists (GLP-1RAs) and pancreatic ductal adenocarcinoma (PDAC). Her project stems from understanding whether and how GLP-1RAs modulate risk of PDAC development. Outside of research, Christy is passionate about cultivating an indoor jungle of houseplants.

Last Updated on March 11, 2026.

Departments & Organizations

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Christy Zheng's published research.

Publications

2026

  • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
    Garcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.
    Peer-Reviewed Original Research
    This study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.